Ticker Details
Xeris Pharmaceuticals, Inc.
IPO Date:	June 22, 2018
Sector:	Healthcare
Market Cap:	$1.04B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.18 | 3.31%
Avg Daily Range (30 D):	$0.16 | 2.72%
Avg Daily Range (90 D):	$0.15 | 2.21%

Institutional Daily Volume
Avg Daily Volume:	1.47M
Avg Daily Volume (30 D):	1.75M
Avg Daily Volume (90 D):	1.67M

Trade Size
Avg Trade Size (Sh.):	204
Avg Trade Size (Sh.) (30 D):	108
Avg Trade Size (Sh.) (90 D):	108

Institutional Trades
Total Institutional Trades:	574
Avg Institutional Trade:	$1.75M
Avg Institutional Trade (30 D):	$1.41M
Avg Institutional Trade (90 D):	$1.75M
Avg Institutional Trade Volume:	.33M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$1.87M
Avg Closing Trade (30 D):	$1.55M
Avg Closing Trade (90 D):	$1.69M
Avg Closing Volume:	336.32K

News

Aug 7, 2025 @ 3:55 PM Xeris (XERS) Q2 Revenue Jumps 49% Source: Jesterai

May 9, 2024 @ 12:10 PM Xeris Biopharma (XERS) Reports Q1 Loss, Lags Reven... Source: Zacks Equity Research

Apr 17, 2024 @ 11:24 AM Strength Seen in MediWound (MDWD): Can Its 14.3% J... Source: Zacks Equity Research

Mar 30, 2024 @ 5:28 AM Xeris Biopharma: Checking-In On One Of My 'Top Ide... Source: Biologics

Mar 5, 2024 @ 2:42 PM Why Xeris (XERS) Might Surprise This Earnings Seas... Source: Zacks Equity Research

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$	$.07	$
Diluted EPS	$	$.07	$
Revenue	$291.85M	$85.81M	$291.85M
Gross Profit
Net Income / Loss	$.55M	$11.08M	$.55M
Operating Income / Loss	$24.9M	$16.77M	$24.9M
Cost of Revenue
Net Cash Flow	$39.32M	$19.44M	$39.32M
PE Ratio